Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Purchased by Mutual Advisors LLC

Mutual Advisors LLC increased its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 20.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 14,617 shares of the pharmacy operator’s stock after purchasing an additional 2,477 shares during the quarter. Mutual Advisors LLC’s holdings in Walgreens Boots Alliance were worth $136,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Charles Schwab Investment Management Inc. lifted its holdings in shares of Walgreens Boots Alliance by 43.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after purchasing an additional 3,329,857 shares during the period. Altrius Capital Management Inc lifted its holdings in shares of Walgreens Boots Alliance by 76.6% during the third quarter. Altrius Capital Management Inc now owns 440,483 shares of the pharmacy operator’s stock worth $3,947,000 after purchasing an additional 190,996 shares during the period. PNC Financial Services Group Inc. lifted its holdings in shares of Walgreens Boots Alliance by 23.4% during the third quarter. PNC Financial Services Group Inc. now owns 340,431 shares of the pharmacy operator’s stock worth $3,050,000 after purchasing an additional 64,586 shares during the period. Sasco Capital Inc. CT lifted its holdings in shares of Walgreens Boots Alliance by 13.6% during the third quarter. Sasco Capital Inc. CT now owns 1,041,440 shares of the pharmacy operator’s stock worth $9,331,000 after purchasing an additional 124,950 shares during the period. Finally, Sunbelt Securities Inc. raised its position in Walgreens Boots Alliance by 82.8% in the third quarter. Sunbelt Securities Inc. now owns 139,377 shares of the pharmacy operator’s stock worth $1,249,000 after acquiring an additional 63,149 shares in the last quarter. 58.59% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on WBA shares. Evercore ISI increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. Barclays increased their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 16th. TD Cowen cut their price objective on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, October 22nd. Jefferies Financial Group cut their price objective on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, October 23rd. Finally, UBS Group increased their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday, October 17th. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus price target of $13.27.

Walgreens Boots Alliance Trading Up 3.3 %

Shares of WBA stock opened at $11.25 on Thursday. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $23.76. The stock has a market cap of $9.72 billion, a P/E ratio of -1.10, a P/E/G ratio of 1.46 and a beta of 0.64. The business has a fifty day simple moving average of $9.96 and a 200-day simple moving average of $9.86. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. The firm had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.66 EPS. On average, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.59 earnings per share for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.